TrialClinical cardiology2018

Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial.

José C Nicolau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.